7Treatment Options for EGFR-Positive Lung Cancer Diagnosis
There are many treatment options for people with EGFR-positive lung cancer. These include chemotherapy, surgery, immunotherapy, or clinical trials. In addition, a doctor may suggest targeted therapies, which aim at eliminating specific proteins or genes of cancer cells.
During target therapy for treating EGFR-positive lung cancer, you will be prescribed with EGFR inhibitors. These medications work by blocking the signals from the EGFR protein, which stimulate cell division. Common EGFR inhibitors include amivantamab, dacomitinib, necitumumab, osimertinib, erlotinib, gefitinib, and afatinib. You can take these drugs at any stage of cancer.
Even though EGFR inhibitors are effective at treating EGFR-positive lung cancer, it only helps control the division of EGFR mutations for a few months or years. After this period, the condition starts to resist the medications. There may also be certain side effects, such as loss of appetite, mouth sores, diarrhea, and skin issues. It is important to consult a healthcare provider to choose the best treatment option. [8]
